
Byrna Technologies reports Q2 revenue contraction, shifts strategy amid operational pivot
- Net revenue for the second quarter fell 43% year-over-year to $16.4 million.
- Gross profit shrunk to $1.8 million following a $5.9 million inventory write-down.
- The company entered a binding deal to acquire HERO Defense Systems while closing its Fort Wayne plant.
Byrna Technologies (NASDAQ:BYRN) reported a steep contraction in its financial metrics for the second quarter of 2026, navigating a heavy product restructuring phase marked by deep asset write-downs and an overhaul of its manufacturing footprint.
The less-lethal defense technology manufacturer recorded net revenue of $16.4 million for the three months ended May 31, 2026, representing a 43% decline compared to the $28.5 million generated in the identical period last fiscal year.
The company reported a statutory net loss of $10.1 million for the quarter, a significant decline from the net income of $2.4 million logged in Q2 2025.
Gross profit landed at $1.8 million, translating to an 11% gross margin.
This compression was heavily driven by a non-recurring $5.9 million inventory write-down alongside a $3.5 million specialized equipment impairment charge.
On an adjusted basis, the consumer safety brand recorded an adjusted EBITDA of $(0.6) million.
To simplify its cost structures, Byrna finalized a plan to shut down its ammunition manufacturing plant in Fort Wayne, Indiana, centralizing its supply chains to eliminate persistent factory underutilization.
On the growth side, the company signed a binding agreement to acquire HERO Defense Systems, a move expected to consolidate intellectual property and expand its less-lethal product pipeline.
Concurrently, Byrna launched several high-conversion Direct-to-Consumer (DTC) pilot marketing campaigns to lower customer acquisition costs and boost digital retail conversion metrics heading into the back half of the fiscal year.
Frequently asked questions
More from United States
Amazon Q3 revenue accelerates 12% to $201.9 billion as AWS growth accelerates
Intel Q3 revenue skyrockets 21% to $16.5B as data center sales surge
Merck raises FY profit outlook as Q3 revenue climbs 5% to $18.1B
Eli Lilly Q3 revenue surges 39% to $24.4 billion as guidance rises
Enterprise Products Q3 EBITDA jumps 16% to $2.8 billion
KBR Q3 revenue rises 5% to $2 billion as adjusted EBITDA grows 12%